Related Experiment Video
Updated: Aug 16, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Geospatial Discrepancy of Chronic Hepatitis B and Hepatitis D Testing in Alberta: A Population-Based Spatial Analysis
Bryce Tkachuk1, Isabelle Couloigner2, Carla S Coffin1
1Division of Gastroenterology and Hepatology, Department of Medicine, Cumming, School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Insights
Chronic hepatitis B (CHB) and hepatitis D virus (HDV) coinfection are significant health concerns. Anti-HDV testing in Alberta is infrequent and poorly aligned with CHB hotspots, suggesting a need for improved testing strategies.
Area of Science:
- Hepatology and infectious diseases
- Public health and epidemiology
- Geographic health analysis
Background:
- Chronic hepatitis B (CHB) and hepatitis D virus (HDV) coinfection are leading causes of cirrhosis and liver cancer.
- The geographic distribution of CHB and the alignment of anti-HDV testing with CHB burden are not well understood.
- Understanding these patterns is crucial for effective public health interventions.
Purpose of the Study:
- To investigate the geographic distribution of CHB prevalence in Alberta.
- To assess the alignment of anti-HDV testing and seropositivity with areas of high CHB burden.
- To identify potential gaps in current testing strategies for CHB and HDV coinfection.
Main Methods:
- Utilized a provincial laboratory database (2014-2022) to identify adults with CHB using a validated serologic algorithm.
- Geolocated CHB cases to Aggregate Dissemination Areas (ADAs) and linked them to health zones and rural-urban classifications.
- Calculated age- and sex-standardized CHB prevalence and employed spatial analysis techniques (descriptive mapping, spatial autocorrelation, hotspot analysis) to assess geographic clustering.
Main Results:
- Identified 8317 persons with CHB, with a provincial prevalence of 1.70 per 1000 population.
- CHB prevalence was highest in metropolitan areas (2.15 per 1000) and lower in remote regions (0.40 per 1000), with notable differences between Calgary and Edmonton.
- Only 17.5% of CHB patients were tested for anti-HDV, and 4.1% of those tested were positive. CHB prevalence hotspots were concentrated in metropolitan ADAs, but anti-HDV testing and positivity hotspots showed only partial overlap.
Conclusions:
- CHB burden in Alberta is geographically clustered, particularly in urban neighborhoods.
- Anti-HDV testing rates are low and do not fully align with areas of high CHB prevalence.
- Implementing reflex or systematic anti-HDV testing, coupled with geographically targeted outreach, could enhance case detection and management.
Abstract:
Chronic hepatitis B (CHB) and hepatitis D virus (HDV) coinfection are major causes of cirrhosis and hepatocellular carcinoma. The geographic distribution of CHB and alignment of anti-HDV testing with CHB burden remain poorly defined. We aimed to examine if anti-HDV testing and seropositivity align with areas of highest CHB burden. Adults with CHB (2014-2022) were identified using a validated serologic algorithm in the provincial laboratory database capturing HBV/HDV serology. Cases were geolocated to Aggregate Dissemination Areas (ADAs), linked to Alberta Health Services zones and rural-urban continuum levels. Age- and sex-standardized CHB prevalence was calculated per ADA using the 2016 Canadian Census. Descriptive mapping, global spatial autocorrelation and local hotspot analysis were used to assess spatial clustering. Among 8317 persons with CHB, the provincial age- and sex-standardized prevalence was 1.70 per 1000 population (95% CI, 1.66-1.74). Prevalence ranged from 2.15 per 1000 in metropolitan areas to 0.40 per 1000 in remote regions and was higher in Calgary than Edmonton (2.53 vs. 1.73 per 1000). Overall, 17.5% of CHB patients were tested for anti-HDV, and 4.1% of those tested were anti-HDV positive. CHB prevalence hotspots were concentrated in metropolitan ADAs, whereas hotspots of anti-HDV testing and positivity showed only partial overlap with these high-burden areas. CHB burden in Alberta is geographically clustered, particularly within specific neighbourhoods of metropolitan cities, whereas anti-HDV testing remains infrequent and only partially aligned with high-burden areas. Reflex or systematic anti-HDV testing, paired with geographically informed outreach, may improve case detection.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction